nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—PRDX5—myometrium—sarcoma	0.021	0.0651	CbGeAlD
Auranofin—PRDX5—embryo—sarcoma	0.0202	0.0626	CbGeAlD
Auranofin—PRDX5—seminal vesicle—sarcoma	0.019	0.0588	CbGeAlD
Auranofin—PRDX5—hematopoietic system—sarcoma	0.018	0.0559	CbGeAlD
Auranofin—PRDX5—connective tissue—sarcoma	0.0174	0.0538	CbGeAlD
Auranofin—PRDX5—skin of body—sarcoma	0.0157	0.0486	CbGeAlD
Auranofin—PRDX5—cardiac atrium—sarcoma	0.0137	0.0424	CbGeAlD
Auranofin—PRDX5—uterus—sarcoma	0.0136	0.0422	CbGeAlD
Auranofin—PRDX5—lymphoid tissue—sarcoma	0.0127	0.0393	CbGeAlD
Auranofin—IKBKB—myometrium—sarcoma	0.0124	0.0385	CbGeAlD
Auranofin—IKBKB—embryo—sarcoma	0.012	0.0371	CbGeAlD
Auranofin—PRDX5—tendon—sarcoma	0.0119	0.037	CbGeAlD
Auranofin—PRDX5—bone marrow—sarcoma	0.0116	0.0358	CbGeAlD
Auranofin—IKBKB—hematopoietic system—sarcoma	0.0107	0.0331	CbGeAlD
Auranofin—IKBKB—connective tissue—sarcoma	0.0103	0.0318	CbGeAlD
Auranofin—ALB—mammary gland—sarcoma	0.0102	0.0317	CbGeAlD
Auranofin—PRDX5—testis—sarcoma	0.00988	0.0306	CbGeAlD
Auranofin—Interstitial pneumonia—Mitoxantrone—sarcoma	0.00951	0.029	CcSEcCtD
Auranofin—IKBKB—smooth muscle tissue—sarcoma	0.0094	0.0291	CbGeAlD
Auranofin—PRDX5—liver—sarcoma	0.00934	0.0289	CbGeAlD
Auranofin—IKBKB—skin of body—sarcoma	0.00928	0.0288	CbGeAlD
Auranofin—IKBKB—uterus—sarcoma	0.00806	0.025	CbGeAlD
Auranofin—Interstitial pneumonia—Etoposide—sarcoma	0.00791	0.0241	CcSEcCtD
Auranofin—IKBKB—lymphoid tissue—sarcoma	0.00752	0.0233	CbGeAlD
Auranofin—PRDX5—lymph node—sarcoma	0.00716	0.0222	CbGeAlD
Auranofin—IKBKB—tendon—sarcoma	0.00707	0.0219	CbGeAlD
Auranofin—Interstitial lung disease—Mitoxantrone—sarcoma	0.0065	0.0198	CcSEcCtD
Auranofin—IKBKB—testis—sarcoma	0.00585	0.0181	CbGeAlD
Auranofin—IKBKB—liver—sarcoma	0.00553	0.0171	CbGeAlD
Auranofin—Interstitial lung disease—Etoposide—sarcoma	0.0054	0.0165	CcSEcCtD
Auranofin—Proteinuria—Mitoxantrone—sarcoma	0.00523	0.016	CcSEcCtD
Auranofin—Protein urine present—Mitoxantrone—sarcoma	0.00516	0.0157	CcSEcCtD
Auranofin—Aplastic anaemia—Dactinomycin—sarcoma	0.00496	0.0151	CcSEcCtD
Auranofin—Hepatic enzyme increased—Mitoxantrone—sarcoma	0.00486	0.0148	CcSEcCtD
Auranofin—IKBKB—lymph node—sarcoma	0.00424	0.0131	CbGeAlD
Auranofin—ALB—testis—sarcoma	0.00342	0.0106	CbGeAlD
Auranofin—Gastrointestinal haemorrhage—Mitoxantrone—sarcoma	0.00334	0.0102	CcSEcCtD
Auranofin—Dysphagia—Dactinomycin—sarcoma	0.00332	0.0101	CcSEcCtD
Auranofin—ALB—liver—sarcoma	0.00323	0.01	CbGeAlD
Auranofin—Pancytopenia—Thiotepa—sarcoma	0.00317	0.00967	CcSEcCtD
Auranofin—Pancytopenia—Dactinomycin—sarcoma	0.00315	0.0096	CcSEcCtD
Auranofin—Neutropenia—Dactinomycin—sarcoma	0.0031	0.00945	CcSEcCtD
Auranofin—Stomatitis—Thiotepa—sarcoma	0.0029	0.00885	CcSEcCtD
Auranofin—Jaundice—Thiotepa—sarcoma	0.0029	0.00885	CcSEcCtD
Auranofin—Conjunctivitis—Thiotepa—sarcoma	0.0029	0.00882	CcSEcCtD
Auranofin—Stomatitis—Dactinomycin—sarcoma	0.00288	0.00878	CcSEcCtD
Auranofin—Haematuria—Thiotepa—sarcoma	0.00284	0.00866	CcSEcCtD
Auranofin—Pancytopenia—Vincristine—sarcoma	0.00281	0.00857	CcSEcCtD
Auranofin—Agranulocytosis—Thiotepa—sarcoma	0.00278	0.00847	CcSEcCtD
Auranofin—Neutropenia—Vincristine—sarcoma	0.00277	0.00844	CcSEcCtD
Auranofin—Agranulocytosis—Dactinomycin—sarcoma	0.00276	0.00841	CcSEcCtD
Auranofin—Pancytopenia—Mitoxantrone—sarcoma	0.00274	0.00835	CcSEcCtD
Auranofin—Gingivitis—Epirubicin—sarcoma	0.00273	0.00833	CcSEcCtD
Auranofin—Neutropenia—Mitoxantrone—sarcoma	0.0027	0.00822	CcSEcCtD
Auranofin—Weight decreased—Vincristine—sarcoma	0.00268	0.00817	CcSEcCtD
Auranofin—Weight decreased—Mitoxantrone—sarcoma	0.00261	0.00796	CcSEcCtD
Auranofin—Neuropathy peripheral—Vincristine—sarcoma	0.00259	0.00789	CcSEcCtD
Auranofin—Stomatitis—Vincristine—sarcoma	0.00257	0.00785	CcSEcCtD
Auranofin—Gingivitis—Doxorubicin—sarcoma	0.00253	0.0077	CcSEcCtD
Auranofin—Stomatitis—Mitoxantrone—sarcoma	0.00251	0.00764	CcSEcCtD
Auranofin—Jaundice—Mitoxantrone—sarcoma	0.00251	0.00764	CcSEcCtD
Auranofin—Conjunctivitis—Mitoxantrone—sarcoma	0.0025	0.00762	CcSEcCtD
Auranofin—Eye disorder—Thiotepa—sarcoma	0.0025	0.00762	CcSEcCtD
Auranofin—ALB—lymph node—sarcoma	0.00248	0.00767	CbGeAlD
Auranofin—Haematuria—Mitoxantrone—sarcoma	0.00245	0.00748	CcSEcCtD
Auranofin—Agranulocytosis—Mitoxantrone—sarcoma	0.0024	0.00732	CcSEcCtD
Auranofin—Dysphagia—Etoposide—sarcoma	0.0024	0.00731	CcSEcCtD
Auranofin—Alopecia—Thiotepa—sarcoma	0.00236	0.0072	CcSEcCtD
Auranofin—Alopecia—Dactinomycin—sarcoma	0.00235	0.00715	CcSEcCtD
Auranofin—Glossitis—Epirubicin—sarcoma	0.00233	0.00709	CcSEcCtD
Auranofin—Pancytopenia—Etoposide—sarcoma	0.00228	0.00695	CcSEcCtD
Auranofin—Neutropenia—Etoposide—sarcoma	0.00224	0.00684	CcSEcCtD
Auranofin—Glossitis—Doxorubicin—sarcoma	0.00215	0.00656	CcSEcCtD
Auranofin—Anaemia—Thiotepa—sarcoma	0.00215	0.00656	CcSEcCtD
Auranofin—Anaemia—Dactinomycin—sarcoma	0.00214	0.00651	CcSEcCtD
Auranofin—Neuropathy peripheral—Etoposide—sarcoma	0.0021	0.00639	CcSEcCtD
Auranofin—Alopecia—Vincristine—sarcoma	0.0021	0.00639	CcSEcCtD
Auranofin—Melaena—Epirubicin—sarcoma	0.00209	0.00638	CcSEcCtD
Auranofin—Stomatitis—Etoposide—sarcoma	0.00209	0.00636	CcSEcCtD
Auranofin—Jaundice—Etoposide—sarcoma	0.00209	0.00636	CcSEcCtD
Auranofin—Leukopenia—Thiotepa—sarcoma	0.00208	0.00635	CcSEcCtD
Auranofin—Leukopenia—Dactinomycin—sarcoma	0.00207	0.0063	CcSEcCtD
Auranofin—Alopecia—Mitoxantrone—sarcoma	0.00204	0.00622	CcSEcCtD
Auranofin—Aplastic anaemia—Epirubicin—sarcoma	0.00201	0.00614	CcSEcCtD
Auranofin—Agranulocytosis—Etoposide—sarcoma	0.002	0.00609	CcSEcCtD
Auranofin—Dysgeusia—Mitoxantrone—sarcoma	0.00197	0.006	CcSEcCtD
Auranofin—Melaena—Doxorubicin—sarcoma	0.00194	0.00591	CcSEcCtD
Auranofin—Anaemia—Vincristine—sarcoma	0.00191	0.00581	CcSEcCtD
Auranofin—Aplastic anaemia—Doxorubicin—sarcoma	0.00186	0.00568	CcSEcCtD
Auranofin—Thrombocytopenia—Thiotepa—sarcoma	0.00186	0.00567	CcSEcCtD
Auranofin—Anaemia—Mitoxantrone—sarcoma	0.00186	0.00566	CcSEcCtD
Auranofin—Leukopenia—Vincristine—sarcoma	0.00185	0.00563	CcSEcCtD
Auranofin—Thrombocytopenia—Dactinomycin—sarcoma	0.00185	0.00563	CcSEcCtD
Auranofin—Anorexia—Thiotepa—sarcoma	0.00181	0.00552	CcSEcCtD
Auranofin—Leukopenia—Mitoxantrone—sarcoma	0.0018	0.00548	CcSEcCtD
Auranofin—Anorexia—Dactinomycin—sarcoma	0.0018	0.00548	CcSEcCtD
Auranofin—Eye disorder—Etoposide—sarcoma	0.00179	0.00547	CcSEcCtD
Auranofin—Alopecia—Etoposide—sarcoma	0.0017	0.00517	CcSEcCtD
Auranofin—Dyspepsia—Thiotepa—sarcoma	0.00167	0.0051	CcSEcCtD
Auranofin—Decreased appetite—Thiotepa—sarcoma	0.00165	0.00503	CcSEcCtD
Auranofin—Dermatitis exfoliative—Epirubicin—sarcoma	0.00165	0.00503	CcSEcCtD
Auranofin—Thrombocytopenia—Vincristine—sarcoma	0.00165	0.00503	CcSEcCtD
Auranofin—Decreased appetite—Dactinomycin—sarcoma	0.00164	0.005	CcSEcCtD
Auranofin—Dysgeusia—Etoposide—sarcoma	0.00164	0.00499	CcSEcCtD
Auranofin—Constipation—Thiotepa—sarcoma	0.00162	0.00495	CcSEcCtD
Auranofin—Thrombocytopenia—Mitoxantrone—sarcoma	0.00161	0.0049	CcSEcCtD
Auranofin—Anorexia—Vincristine—sarcoma	0.00161	0.00489	CcSEcCtD
Auranofin—Anorexia—Mitoxantrone—sarcoma	0.00156	0.00477	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Epirubicin—sarcoma	0.00156	0.00474	CcSEcCtD
Auranofin—Gastrointestinal pain—Thiotepa—sarcoma	0.00155	0.00473	CcSEcCtD
Auranofin—Anaemia—Etoposide—sarcoma	0.00155	0.00471	CcSEcCtD
Auranofin—Gastrointestinal pain—Dactinomycin—sarcoma	0.00154	0.0047	CcSEcCtD
Auranofin—IKBKB—Validated transcriptional targets of TAp63 isoforms—MDM2—sarcoma	0.00154	0.00442	CbGpPWpGaD
Auranofin—Dermatitis exfoliative—Doxorubicin—sarcoma	0.00153	0.00465	CcSEcCtD
Auranofin—ALB—Selenium Micronutrient Network—HBA1—sarcoma	0.00152	0.00434	CbGpPWpGaD
Auranofin—Urticaria—Thiotepa—sarcoma	0.00151	0.0046	CcSEcCtD
Auranofin—Abdominal pain—Thiotepa—sarcoma	0.0015	0.00458	CcSEcCtD
Auranofin—Leukopenia—Etoposide—sarcoma	0.0015	0.00456	CcSEcCtD
Auranofin—Abdominal pain—Dactinomycin—sarcoma	0.00149	0.00454	CcSEcCtD
Auranofin—IKBKB—AGE/RAGE pathway—MMP2—sarcoma	0.00148	0.00423	CbGpPWpGaD
Auranofin—Decreased appetite—Vincristine—sarcoma	0.00146	0.00446	CcSEcCtD
Auranofin—Dyspepsia—Mitoxantrone—sarcoma	0.00144	0.0044	CcSEcCtD
Auranofin—Constipation—Vincristine—sarcoma	0.00144	0.00439	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.00144	0.00439	CcSEcCtD
Auranofin—IKBKB—FoxO family signaling—CTNNB1—sarcoma	0.00144	0.00412	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—CREB1—sarcoma	0.00143	0.0041	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—CREB1—sarcoma	0.00143	0.0041	CbGpPWpGaD
Auranofin—Decreased appetite—Mitoxantrone—sarcoma	0.00143	0.00435	CcSEcCtD
Auranofin—IKBKB—Interleukin-11 Signaling Pathway—SRC—sarcoma	0.00142	0.00406	CbGpPWpGaD
Auranofin—Constipation—Mitoxantrone—sarcoma	0.0014	0.00428	CcSEcCtD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—PLCG1—sarcoma	0.0014	0.00401	CbGpPWpGaD
Auranofin—Gastrointestinal pain—Vincristine—sarcoma	0.00138	0.0042	CcSEcCtD
Auranofin—IKBKB—GMCSF-mediated signaling events—KRAS—sarcoma	0.00135	0.00386	CbGpPWpGaD
Auranofin—Dysphagia—Epirubicin—sarcoma	0.00135	0.0041	CcSEcCtD
Auranofin—Pruritus—Thiotepa—sarcoma	0.00134	0.0041	CcSEcCtD
Auranofin—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00134	0.00409	CcSEcCtD
Auranofin—Thrombocytopenia—Etoposide—sarcoma	0.00134	0.00407	CcSEcCtD
Auranofin—Eosinophilia—Epirubicin—sarcoma	0.00133	0.00406	CcSEcCtD
Auranofin—Abdominal pain—Vincristine—sarcoma	0.00133	0.00406	CcSEcCtD
Auranofin—IKBKB—IL-1 signaling pathway—JUN—sarcoma	0.00132	0.00378	CbGpPWpGaD
Auranofin—IKBKB—RANKL/RANK Signaling Pathway—JUN—sarcoma	0.00132	0.00378	CbGpPWpGaD
Auranofin—IKBKB—Hair Follicle Development: Induction (Part 1 of 3)—MYC—sarcoma	0.00132	0.00377	CbGpPWpGaD
Auranofin—Urticaria—Mitoxantrone—sarcoma	0.0013	0.00397	CcSEcCtD
Auranofin—Anorexia—Etoposide—sarcoma	0.0013	0.00396	CcSEcCtD
Auranofin—Diarrhoea—Thiotepa—sarcoma	0.0013	0.00396	CcSEcCtD
Auranofin—Abdominal pain—Mitoxantrone—sarcoma	0.0013	0.00395	CcSEcCtD
Auranofin—IKBKB—B Cell Activation—PLCG1—sarcoma	0.0013	0.00371	CbGpPWpGaD
Auranofin—IKBKB—MyD88 cascade initiated on plasma membrane—CREB1—sarcoma	0.0013	0.00371	CbGpPWpGaD
Auranofin—Diarrhoea—Dactinomycin—sarcoma	0.00129	0.00393	CcSEcCtD
Auranofin—IKBKB—Hair Follicle Development: Induction (Part 1 of 3)—EGFR—sarcoma	0.00129	0.00369	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—CREB1—sarcoma	0.00128	0.00368	CbGpPWpGaD
Auranofin—Pancytopenia—Epirubicin—sarcoma	0.00128	0.00389	CcSEcCtD
Auranofin—IKBKB—MyD88 dependent cascade initiated on endosome—CREB1—sarcoma	0.00126	0.00361	CbGpPWpGaD
Auranofin—Neutropenia—Epirubicin—sarcoma	0.00126	0.00383	CcSEcCtD
Auranofin—Dysphagia—Doxorubicin—sarcoma	0.00124	0.00379	CcSEcCtD
Auranofin—IKBKB—TCR Signaling Pathway—CREB1—sarcoma	0.00124	0.00355	CbGpPWpGaD
Auranofin—Eosinophilia—Doxorubicin—sarcoma	0.00123	0.00376	CcSEcCtD
Auranofin—Weight decreased—Epirubicin—sarcoma	0.00122	0.00371	CcSEcCtD
Auranofin—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—CREB1—sarcoma	0.00122	0.00348	CbGpPWpGaD
Auranofin—IKBKB—Fc-epsilon receptor I signaling in mast cells—JUN—sarcoma	0.00122	0.00348	CbGpPWpGaD
Auranofin—Vomiting—Thiotepa—sarcoma	0.00121	0.00368	CcSEcCtD
Auranofin—Vomiting—Dactinomycin—sarcoma	0.0012	0.00365	CcSEcCtD
Auranofin—Rash—Thiotepa—sarcoma	0.0012	0.00365	CcSEcCtD
Auranofin—Dermatitis—Thiotepa—sarcoma	0.0012	0.00365	CcSEcCtD
Auranofin—IKBKB—MyD88:Mal cascade initiated on plasma membrane—CREB1—sarcoma	0.0012	0.00342	CbGpPWpGaD
Auranofin—Rash—Dactinomycin—sarcoma	0.00119	0.00362	CcSEcCtD
Auranofin—Decreased appetite—Etoposide—sarcoma	0.00119	0.00362	CcSEcCtD
Auranofin—IKBKB—RANKL/RANK Signaling Pathway—SRC—sarcoma	0.00118	0.00339	CbGpPWpGaD
Auranofin—Pancytopenia—Doxorubicin—sarcoma	0.00118	0.0036	CcSEcCtD
Auranofin—Neuropathy peripheral—Epirubicin—sarcoma	0.00118	0.00358	CcSEcCtD
Auranofin—IKBKB—TCR signaling in naïve CD8+ T cells—NRAS—sarcoma	0.00117	0.00336	CbGpPWpGaD
Auranofin—Stomatitis—Epirubicin—sarcoma	0.00117	0.00356	CcSEcCtD
Auranofin—Jaundice—Epirubicin—sarcoma	0.00117	0.00356	CcSEcCtD
Auranofin—Constipation—Etoposide—sarcoma	0.00117	0.00356	CcSEcCtD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—CREB1—sarcoma	0.00117	0.00334	CbGpPWpGaD
Auranofin—Conjunctivitis—Epirubicin—sarcoma	0.00117	0.00355	CcSEcCtD
Auranofin—Neutropenia—Doxorubicin—sarcoma	0.00116	0.00355	CcSEcCtD
Auranofin—ALB—FOXA2 and FOXA3 transcription factor networks—CREB1—sarcoma	0.00116	0.00332	CbGpPWpGaD
Auranofin—Diarrhoea—Vincristine—sarcoma	0.00115	0.00351	CcSEcCtD
Auranofin—IKBKB—MyD88-independent cascade—CREB1—sarcoma	0.00115	0.00329	CbGpPWpGaD
Auranofin—IKBKB—GMCSF-mediated signaling events—HRAS—sarcoma	0.00114	0.00328	CbGpPWpGaD
Auranofin—Haematuria—Epirubicin—sarcoma	0.00114	0.00349	CcSEcCtD
Auranofin—IKBKB—AGE/RAGE pathway—JUN—sarcoma	0.00114	0.00327	CbGpPWpGaD
Auranofin—IKBKB—Cytosolic sensors of pathogen-associated DNA—CTNNB1—sarcoma	0.00113	0.00324	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—IGF1R—sarcoma	0.00113	0.00324	CbGpPWpGaD
Auranofin—Nausea—Thiotepa—sarcoma	0.00113	0.00344	CcSEcCtD
Auranofin—IKBKB—BCR signaling pathway—JUN—sarcoma	0.00113	0.00323	CbGpPWpGaD
Auranofin—Weight decreased—Doxorubicin—sarcoma	0.00113	0.00343	CcSEcCtD
Auranofin—Diarrhoea—Mitoxantrone—sarcoma	0.00112	0.00342	CcSEcCtD
Auranofin—Nausea—Dactinomycin—sarcoma	0.00112	0.00341	CcSEcCtD
Auranofin—Agranulocytosis—Epirubicin—sarcoma	0.00112	0.00341	CcSEcCtD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—CTNNB1—sarcoma	0.00112	0.0032	CbGpPWpGaD
Auranofin—Gastrointestinal pain—Etoposide—sarcoma	0.00112	0.0034	CcSEcCtD
Auranofin—Neuropathy peripheral—Doxorubicin—sarcoma	0.00109	0.00332	CcSEcCtD
Auranofin—Urticaria—Etoposide—sarcoma	0.00108	0.0033	CcSEcCtD
Auranofin—IKBKB—Apoptosis—MDM2—sarcoma	0.00108	0.0031	CbGpPWpGaD
Auranofin—Jaundice—Doxorubicin—sarcoma	0.00108	0.0033	CcSEcCtD
Auranofin—Stomatitis—Doxorubicin—sarcoma	0.00108	0.0033	CcSEcCtD
Auranofin—Abdominal pain—Etoposide—sarcoma	0.00108	0.00329	CcSEcCtD
Auranofin—Conjunctivitis—Doxorubicin—sarcoma	0.00108	0.00329	CcSEcCtD
Auranofin—IKBKB—Insulin Signaling—FOXO1—sarcoma	0.00108	0.00309	CbGpPWpGaD
Auranofin—Vomiting—Vincristine—sarcoma	0.00107	0.00326	CcSEcCtD
Auranofin—Rash—Vincristine—sarcoma	0.00106	0.00324	CcSEcCtD
Auranofin—Dermatitis—Vincristine—sarcoma	0.00106	0.00323	CcSEcCtD
Auranofin—Haematuria—Doxorubicin—sarcoma	0.00106	0.00322	CcSEcCtD
Auranofin—Vomiting—Mitoxantrone—sarcoma	0.00104	0.00318	CcSEcCtD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—FOXO1—sarcoma	0.00104	0.00298	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—PDGFRB—sarcoma	0.00104	0.00298	CbGpPWpGaD
Auranofin—Visual impairment—Epirubicin—sarcoma	0.00104	0.00316	CcSEcCtD
Auranofin—Agranulocytosis—Doxorubicin—sarcoma	0.00104	0.00316	CcSEcCtD
Auranofin—Rash—Mitoxantrone—sarcoma	0.00103	0.00315	CcSEcCtD
Auranofin—IKBKB—MAPK Signaling Pathway—PDGFRB—sarcoma	0.00103	0.00296	CbGpPWpGaD
Auranofin—Dermatitis—Mitoxantrone—sarcoma	0.00103	0.00315	CcSEcCtD
Auranofin—IKBKB—Leptin signaling pathway—CCND1—sarcoma	0.00103	0.00296	CbGpPWpGaD
Auranofin—IKBKB—Activated TLR4 signalling—CREB1—sarcoma	0.00103	0.00296	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—JUN—sarcoma	0.00103	0.00295	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—SRC—sarcoma	0.00102	0.00293	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—PDGFRA—sarcoma	0.00102	0.00293	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—SRC—sarcoma	0.00101	0.0029	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD8+ T cells—KRAS—sarcoma	0.00101	0.00289	CbGpPWpGaD
Auranofin—Eye disorder—Epirubicin—sarcoma	0.00101	0.00307	CcSEcCtD
Auranofin—Nausea—Vincristine—sarcoma	0.001	0.00305	CcSEcCtD
Auranofin—IKBKB—Interleukin-11 Signaling Pathway—HRAS—sarcoma	0.000997	0.00285	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—FOXO1—sarcoma	0.000994	0.00285	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—PDGFRB—sarcoma	0.000992	0.00284	CbGpPWpGaD
Auranofin—IKBKB—mTOR signaling pathway—NRAS—sarcoma	0.000985	0.00282	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—NRAS—sarcoma	0.000985	0.00282	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—PDGFRA—sarcoma	0.000977	0.0028	CbGpPWpGaD
Auranofin—Nausea—Mitoxantrone—sarcoma	0.000974	0.00297	CcSEcCtD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—NRAS—sarcoma	0.000973	0.00279	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—CREB1—sarcoma	0.000971	0.00278	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—PLCG1—sarcoma	0.00097	0.00278	CbGpPWpGaD
Auranofin—Pruritus—Etoposide—sarcoma	0.000965	0.00294	CcSEcCtD
Auranofin—Visual impairment—Doxorubicin—sarcoma	0.00096	0.00293	CcSEcCtD
Auranofin—IKBKB—Signaling by NGF—PLCG1—sarcoma	0.000954	0.00273	CbGpPWpGaD
Auranofin—Alopecia—Epirubicin—sarcoma	0.000951	0.0029	CcSEcCtD
Auranofin—IKBKB—Apoptosis—JUN—sarcoma	0.000941	0.00269	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—CTNNB1—sarcoma	0.000934	0.00267	CbGpPWpGaD
Auranofin—Diarrhoea—Etoposide—sarcoma	0.000934	0.00285	CcSEcCtD
Auranofin—IKBKB—MyD88 cascade initiated on plasma membrane—JUN—sarcoma	0.000932	0.00267	CbGpPWpGaD
Auranofin—Eye disorder—Doxorubicin—sarcoma	0.000931	0.00284	CcSEcCtD
Auranofin—IKBKB—Leptin signaling pathway—SRC—sarcoma	0.000924	0.00265	CbGpPWpGaD
Auranofin—Flatulence—Epirubicin—sarcoma	0.000924	0.00281	CcSEcCtD
Auranofin—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—JUN—sarcoma	0.000923	0.00264	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—FOXO1—sarcoma	0.00092	0.00263	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—PDGFRB—sarcoma	0.000918	0.00263	CbGpPWpGaD
Auranofin—Dysgeusia—Epirubicin—sarcoma	0.000918	0.0028	CcSEcCtD
Auranofin—IKBKB—MyD88 dependent cascade initiated on endosome—JUN—sarcoma	0.000907	0.0026	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—ATF1—sarcoma	0.000906	0.0026	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—MYC—sarcoma	0.000906	0.0026	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—PDGFRA—sarcoma	0.000904	0.00259	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—EGFR—sarcoma	0.000897	0.00257	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—JUN—sarcoma	0.00089	0.00255	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—EGFR—sarcoma	0.000887	0.00254	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—JUN—sarcoma	0.000883	0.00253	CbGpPWpGaD
Auranofin—Alopecia—Doxorubicin—sarcoma	0.00088	0.00268	CcSEcCtD
Auranofin—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—JUN—sarcoma	0.000875	0.00251	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—JUN—sarcoma	0.000875	0.00251	CbGpPWpGaD
Auranofin—Vomiting—Etoposide—sarcoma	0.000868	0.00264	CcSEcCtD
Auranofin—Anaemia—Epirubicin—sarcoma	0.000866	0.00264	CcSEcCtD
Auranofin—IKBKB—Toll-Like Receptors Cascades—CREB1—sarcoma	0.000865	0.00248	CbGpPWpGaD
Auranofin—Rash—Etoposide—sarcoma	0.00086	0.00262	CcSEcCtD
Auranofin—IKBKB—MyD88:Mal cascade initiated on plasma membrane—JUN—sarcoma	0.00086	0.00246	CbGpPWpGaD
Auranofin—Dermatitis—Etoposide—sarcoma	0.00086	0.00262	CcSEcCtD
Auranofin—IKBKB—TCR signaling in naïve CD8+ T cells—HRAS—sarcoma	0.000859	0.00246	CbGpPWpGaD
Auranofin—Flatulence—Doxorubicin—sarcoma	0.000855	0.0026	CcSEcCtD
Auranofin—IKBKB—BDNF signaling pathway—CREB1—sarcoma	0.00085	0.00243	CbGpPWpGaD
Auranofin—Dysgeusia—Doxorubicin—sarcoma	0.000849	0.00259	CcSEcCtD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—KRAS—sarcoma	0.000848	0.00243	CbGpPWpGaD
Auranofin—IKBKB—mTOR signaling pathway—KRAS—sarcoma	0.000848	0.00243	CbGpPWpGaD
Auranofin—Leukopenia—Epirubicin—sarcoma	0.000839	0.00256	CcSEcCtD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—JUN—sarcoma	0.000839	0.0024	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—KRAS—sarcoma	0.000838	0.0024	CbGpPWpGaD
Auranofin—IKBKB—MyD88-independent cascade—JUN—sarcoma	0.000825	0.00236	CbGpPWpGaD
Auranofin—Nausea—Etoposide—sarcoma	0.000811	0.00247	CcSEcCtD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—JUN—sarcoma	0.000806	0.00231	CbGpPWpGaD
Auranofin—Anaemia—Doxorubicin—sarcoma	0.000802	0.00244	CcSEcCtD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KIT—sarcoma	0.000793	0.00227	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—IL2—sarcoma	0.000791	0.00227	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—VEGFC—sarcoma	0.000789	0.00226	CbGpPWpGaD
Auranofin—Leukopenia—Doxorubicin—sarcoma	0.000776	0.00237	CcSEcCtD
Auranofin—IKBKB—Fc-epsilon receptor I signaling in mast cells—HRAS—sarcoma	0.000767	0.0022	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—KIT—sarcoma	0.000757	0.00217	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—MYC—sarcoma	0.000756	0.00217	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—CREB1—sarcoma	0.000755	0.00216	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—NRAS—sarcoma	0.000755	0.00216	CbGpPWpGaD
Auranofin—Thrombocytopenia—Epirubicin—sarcoma	0.000749	0.00228	CcSEcCtD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—TP53—sarcoma	0.000744	0.00213	CbGpPWpGaD
Auranofin—IKBKB—Activated TLR4 signalling—JUN—sarcoma	0.000742	0.00213	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD34—sarcoma	0.000739	0.00212	CbGpPWpGaD
Auranofin—Anorexia—Epirubicin—sarcoma	0.000729	0.00222	CcSEcCtD
Auranofin—IKBKB—p75(NTR)-mediated signaling—TP53—sarcoma	0.000727	0.00208	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—CREB1—sarcoma	0.000721	0.00206	CbGpPWpGaD
Auranofin—IKBKB—mTOR signaling pathway—HRAS—sarcoma	0.00072	0.00206	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—HRAS—sarcoma	0.00072	0.00206	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—HRAS—sarcoma	0.000712	0.00204	CbGpPWpGaD
Auranofin—IKBKB—BCR signaling pathway—HRAS—sarcoma	0.000712	0.00204	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—KIT—sarcoma	0.000701	0.00201	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—JUN—sarcoma	0.000698	0.002	CbGpPWpGaD
Auranofin—Thrombocytopenia—Doxorubicin—sarcoma	0.000693	0.00211	CcSEcCtD
Auranofin—IKBKB—Signaling by NGF—FOXO1—sarcoma	0.000677	0.00194	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—PDGFRB—sarcoma	0.000676	0.00194	CbGpPWpGaD
Auranofin—Anorexia—Doxorubicin—sarcoma	0.000675	0.00206	CcSEcCtD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—MYC—sarcoma	0.000674	0.00193	CbGpPWpGaD
Auranofin—Dyspepsia—Epirubicin—sarcoma	0.000673	0.00205	CcSEcCtD
Auranofin—IKBKB—B Cell Activation—CREB1—sarcoma	0.000667	0.00191	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—PDGFRA—sarcoma	0.000665	0.00191	CbGpPWpGaD
Auranofin—Decreased appetite—Epirubicin—sarcoma	0.000665	0.00203	CcSEcCtD
Auranofin—IKBKB—Signaling by Interleukins—NRAS—sarcoma	0.000664	0.0019	CbGpPWpGaD
Auranofin—Constipation—Epirubicin—sarcoma	0.000654	0.00199	CcSEcCtD
Auranofin—IKBKB—Leptin signaling pathway—HRAS—sarcoma	0.00065	0.00186	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—KRAS—sarcoma	0.00065	0.00186	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—JUN—sarcoma	0.000629	0.0018	CbGpPWpGaD
Auranofin—Gastrointestinal pain—Epirubicin—sarcoma	0.000625	0.00191	CcSEcCtD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—MDM2—sarcoma	0.000625	0.00179	CbGpPWpGaD
Auranofin—Dyspepsia—Doxorubicin—sarcoma	0.000623	0.0019	CcSEcCtD
Auranofin—IKBKB—Toll-Like Receptors Cascades—JUN—sarcoma	0.000622	0.00178	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—TP53—sarcoma	0.000621	0.00178	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—IL2—sarcoma	0.00062	0.00178	CbGpPWpGaD
Auranofin—Decreased appetite—Doxorubicin—sarcoma	0.000615	0.00188	CcSEcCtD
Auranofin—IKBKB—BDNF signaling pathway—JUN—sarcoma	0.000611	0.00175	CbGpPWpGaD
Auranofin—Urticaria—Epirubicin—sarcoma	0.000608	0.00185	CcSEcCtD
Auranofin—IKBKB—BDNF signaling pathway—CTNNB1—sarcoma	0.000607	0.00174	CbGpPWpGaD
Auranofin—Constipation—Doxorubicin—sarcoma	0.000605	0.00184	CcSEcCtD
Auranofin—Abdominal pain—Epirubicin—sarcoma	0.000605	0.00184	CcSEcCtD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—MDM2—sarcoma	0.000596	0.00171	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—TP53—sarcoma	0.000583	0.00167	CbGpPWpGaD
Auranofin—Gastrointestinal pain—Doxorubicin—sarcoma	0.000579	0.00176	CcSEcCtD
Auranofin—IKBKB—Signaling by Interleukins—KRAS—sarcoma	0.000572	0.00164	CbGpPWpGaD
Auranofin—Urticaria—Doxorubicin—sarcoma	0.000562	0.00171	CcSEcCtD
Auranofin—IKBKB—TCR Signaling Pathway—HRAS—sarcoma	0.000562	0.00161	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—JUN—sarcoma	0.000562	0.00161	CbGpPWpGaD
Auranofin—Abdominal pain—Doxorubicin—sarcoma	0.000559	0.00171	CcSEcCtD
Auranofin—ALB—Hemostasis—TEK—sarcoma	0.000554	0.00159	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—HRAS—sarcoma	0.000552	0.00158	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—MDM2—sarcoma	0.000552	0.00158	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—SRC—sarcoma	0.000548	0.00157	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PLCG1—sarcoma	0.000544	0.00156	CbGpPWpGaD
Auranofin—Pruritus—Epirubicin—sarcoma	0.000541	0.00165	CcSEcCtD
Auranofin—IKBKB—MAPK Signaling Pathway—JUN—sarcoma	0.00054	0.00155	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PTPRC—sarcoma	0.000534	0.00153	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—HRAS—sarcoma	0.000529	0.00152	CbGpPWpGaD
Auranofin—Diarrhoea—Epirubicin—sarcoma	0.000523	0.0016	CcSEcCtD
Auranofin—IKBKB—Adaptive Immune System—PLCG1—sarcoma	0.000523	0.0015	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—JUN—sarcoma	0.000518	0.00148	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—ATF1—sarcoma	0.000517	0.00148	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—KIT—sarcoma	0.000516	0.00148	CbGpPWpGaD
Auranofin—ALB—Hemostasis—ANGPT2—sarcoma	0.000507	0.00145	CbGpPWpGaD
Auranofin—Pruritus—Doxorubicin—sarcoma	0.000501	0.00153	CcSEcCtD
Auranofin—IKBKB—Signaling by NGF—CREB1—sarcoma	0.000491	0.00141	CbGpPWpGaD
Auranofin—Vomiting—Epirubicin—sarcoma	0.000486	0.00148	CcSEcCtD
Auranofin—IKBKB—Signaling by Interleukins—HRAS—sarcoma	0.000486	0.00139	CbGpPWpGaD
Auranofin—Diarrhoea—Doxorubicin—sarcoma	0.000484	0.00148	CcSEcCtD
Auranofin—Rash—Epirubicin—sarcoma	0.000482	0.00147	CcSEcCtD
Auranofin—Dermatitis—Epirubicin—sarcoma	0.000482	0.00147	CcSEcCtD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—NRAS—sarcoma	0.000469	0.00134	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—NRAS—sarcoma	0.000466	0.00134	CbGpPWpGaD
Auranofin—Nausea—Epirubicin—sarcoma	0.000454	0.00138	CcSEcCtD
Auranofin—ALB—Platelet degranulation—VEGFA—sarcoma	0.000452	0.00129	CbGpPWpGaD
Auranofin—Vomiting—Doxorubicin—sarcoma	0.00045	0.00137	CcSEcCtD
Auranofin—IKBKB—Immune System—CD34—sarcoma	0.000448	0.00128	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—NRAS—sarcoma	0.000447	0.00128	CbGpPWpGaD
Auranofin—Rash—Doxorubicin—sarcoma	0.000446	0.00136	CcSEcCtD
Auranofin—Dermatitis—Doxorubicin—sarcoma	0.000446	0.00136	CcSEcCtD
Auranofin—IKBKB—MAPK Signaling Pathway—MYC—sarcoma	0.000434	0.00124	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—sarcoma	0.00043	0.00123	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—EGFR—sarcoma	0.000427	0.00122	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—EGFR—sarcoma	0.000425	0.00122	CbGpPWpGaD
Auranofin—Nausea—Doxorubicin—sarcoma	0.00042	0.00128	CcSEcCtD
Auranofin—IKBKB—B Cell Activation—NRAS—sarcoma	0.000414	0.00119	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—EGFR—sarcoma	0.000408	0.00117	CbGpPWpGaD
Auranofin—ALB—Hemostasis—VEGFC—sarcoma	0.000407	0.00116	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—MDM2—sarcoma	0.000406	0.00116	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KRAS—sarcoma	0.000403	0.00116	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—KRAS—sarcoma	0.000401	0.00115	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TP53—sarcoma	0.000398	0.00114	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—FOXO1—sarcoma	0.000386	0.00111	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—HRAS—sarcoma	0.000386	0.00111	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PDGFRB—sarcoma	0.000385	0.0011	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—KRAS—sarcoma	0.000385	0.0011	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PDGFRA—sarcoma	0.000379	0.00109	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—EGFR—sarcoma	0.000377	0.00108	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—FOXO1—sarcoma	0.000371	0.00106	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PDGFRB—sarcoma	0.00037	0.00106	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL2—sarcoma	0.000369	0.00106	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PDGFRA—sarcoma	0.000364	0.00104	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TP53—sarcoma	0.000357	0.00102	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—KRAS—sarcoma	0.000356	0.00102	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—HRAS—sarcoma	0.000355	0.00102	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—sarcoma	0.000343	0.000982	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—sarcoma	0.000327	0.000937	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PTPRC—sarcoma	0.000324	0.000928	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PLCG1—sarcoma	0.000319	0.000915	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PLCG1—sarcoma	0.000317	0.000908	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—SRC—sarcoma	0.000317	0.000907	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—NRAS—sarcoma	0.00031	0.000888	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TLE1—sarcoma	0.000309	0.000885	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—NRAS—sarcoma	0.000305	0.000873	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—HRAS—sarcoma	0.000303	0.000867	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ATF1—sarcoma	0.000301	0.000862	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—KIT—sarcoma	0.000294	0.000843	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—KIT—sarcoma	0.000283	0.000809	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CREB1—sarcoma	0.00028	0.000802	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—EGFR—sarcoma	0.000278	0.000795	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CREB1—sarcoma	0.000269	0.00077	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—KRAS—sarcoma	0.000267	0.000764	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—KRAS—sarcoma	0.000262	0.000751	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—VEGFC—sarcoma	0.000261	0.000747	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—IL2—sarcoma	0.000236	0.000675	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MDM2—sarcoma	0.000232	0.000664	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—HRAS—sarcoma	0.000227	0.000649	CbGpPWpGaD
Auranofin—IKBKB—Immune System—FOXO1—sarcoma	0.000225	0.000644	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PDGFRB—sarcoma	0.000225	0.000643	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—HRAS—sarcoma	0.000223	0.000638	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—MDM2—sarcoma	0.000223	0.000637	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PDGFRA—sarcoma	0.000221	0.000633	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FLT1—sarcoma	0.000208	0.000597	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—SRC—sarcoma	0.000206	0.000589	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PLCG1—sarcoma	0.000205	0.000587	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—JUN—sarcoma	0.000201	0.000577	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—VEGFA—sarcoma	0.0002	0.000574	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CTNNB1—sarcoma	0.0002	0.000572	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CXCR4—sarcoma	0.000197	0.000564	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ATF1—sarcoma	0.000195	0.000558	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—SRC—sarcoma	0.000181	0.000517	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—NRAS—sarcoma	0.000174	0.000498	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—SRC—sarcoma	0.000173	0.000497	CbGpPWpGaD
Auranofin—IKBKB—Immune System—KIT—sarcoma	0.000171	0.000491	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—NRAS—sarcoma	0.000167	0.000478	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CREB1—sarcoma	0.000163	0.000467	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—EGFR—sarcoma	0.000158	0.000453	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IGF1R—sarcoma	0.000153	0.000438	CbGpPWpGaD
Auranofin—ALB—Metabolism—ENO2—sarcoma	0.000153	0.000437	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—EGFR—sarcoma	0.000152	0.000435	CbGpPWpGaD
Auranofin—ALB—Metabolism—HBA1—sarcoma	0.000152	0.000434	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—KRAS—sarcoma	0.00015	0.000428	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FOXO1—sarcoma	0.000145	0.000416	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PDGFRB—sarcoma	0.000145	0.000416	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—KRAS—sarcoma	0.000144	0.000411	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PDGFRA—sarcoma	0.000143	0.000409	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MDM2—sarcoma	0.000135	0.000387	CbGpPWpGaD
Auranofin—ALB—Metabolism—PLCG1—sarcoma	0.00013	0.000371	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—HRAS—sarcoma	0.000127	0.000364	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HRAS—sarcoma	0.000122	0.00035	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IL2—sarcoma	0.000122	0.000348	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL2—sarcoma	0.000121	0.000345	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KDR—sarcoma	0.00012	0.000344	CbGpPWpGaD
Auranofin—IKBKB—Immune System—JUN—sarcoma	0.000117	0.000336	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CTNNB1—sarcoma	0.000116	0.000333	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KIT—sarcoma	0.000111	0.000317	CbGpPWpGaD
Auranofin—ALB—Hemostasis—SRC—sarcoma	0.000106	0.000304	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CREB1—sarcoma	0.000105	0.000302	CbGpPWpGaD
Auranofin—IKBKB—Immune System—SRC—sarcoma	0.000105	0.000301	CbGpPWpGaD
Auranofin—ALB—Hemostasis—VEGFA—sarcoma	0.000103	0.000296	CbGpPWpGaD
Auranofin—ALB—Hemostasis—NRAS—sarcoma	0.000102	0.000292	CbGpPWpGaD
Auranofin—IKBKB—Immune System—NRAS—sarcoma	0.000101	0.00029	CbGpPWpGaD
Auranofin—IKBKB—Immune System—EGFR—sarcoma	9.22e-05	0.000264	CbGpPWpGaD
Auranofin—ALB—Hemostasis—KRAS—sarcoma	8.78e-05	0.000252	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MDM2—sarcoma	8.73e-05	0.00025	CbGpPWpGaD
Auranofin—IKBKB—Immune System—KRAS—sarcoma	8.71e-05	0.00025	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TP53—sarcoma	7.81e-05	0.000224	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL2—sarcoma	7.8e-05	0.000223	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCND1—sarcoma	7.6e-05	0.000218	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—JUN—sarcoma	7.58e-05	0.000217	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CTNNB1—sarcoma	7.53e-05	0.000216	CbGpPWpGaD
Auranofin—ALB—Hemostasis—HRAS—sarcoma	7.46e-05	0.000214	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HRAS—sarcoma	7.41e-05	0.000212	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SRC—sarcoma	6.8e-05	0.000195	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—VEGFA—sarcoma	6.63e-05	0.00019	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NRAS—sarcoma	6.54e-05	0.000187	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MYC—sarcoma	6.1e-05	0.000175	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—EGFR—sarcoma	5.96e-05	0.000171	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KRAS—sarcoma	5.63e-05	0.000161	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TP53—sarcoma	5.01e-05	0.000143	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HRAS—sarcoma	4.79e-05	0.000137	CbGpPWpGaD
